Amgen to release Epogen data in face of House panel hearing

06/25/2007 | Forbes

Amgen planned to release data about the dosages of its Epogen anemia drug before today's hearing by a House panel looking into Medicare payments. Critics on the House Ways and Means Subcommittee on Health assert the program's payment system gives doctors an incentive to overprescribe the drug, but Amgen said its data shows physicians have scaled back prescriptions in recent months.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX